Group One Trading’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39.5M | Sell |
1,407,300
-906,500
| -39% | -$24.1M | 0.08% | 246 |
|
|
2025
Q4 | $57.6M | Sell |
2,313,800
-159,200
| -6% | -$4.01M | 0.1% | 174 |
|
|
2025
Q3 | $63M | Sell |
2,473,000
-285,600
| -10% | -$7.05M | 0.11% | 169 |
|
|
2025
Q2 | $66.9M | Sell |
2,758,600
-53,600
| -2% | -$1.25M | 0.15% | 109 |
|
|
2025
Q1 | $71.3M | Buy |
2,812,200
+507,900
| +22% | +$13.3M | 0.21% | 78 |
|
|
2024
Q4 | $61.1M | Buy |
2,304,300
+289,400
| +14% | +$7.85M | 0.14% | 103 |
|
|
2024
Q3 | $58.3M | Buy |
2,014,900
+1,263,000
| +168% | +$36.8M | 0.17% | 88 |
|
|
2024
Q2 | $21M | Buy |
751,900
+700
| +0.1% | +$19.3K | 0.08% | 187 |
|
|
2024
Q1 | $20.8M | Sell |
751,200
-399,800
| -35% | -$11.1M | 0.08% | 182 |
|
|
2023
Q4 | $33.1M | Buy |
1,151,000
+429,400
| +60% | +$13M | 0.09% | 174 |
|
|
2023
Q3 | $23.9M | Sell |
721,600
-54,100
| -7% | -$1.91M | 0.08% | 174 |
|
|
2023
Q2 | $28.5M | Sell |
775,700
-232,200
| -23% | -$9.04M | 0.09% | 147 |
|
|
2023
Q1 | $41.1M | Sell |
1,007,900
-1,165,000
| -54% | -$50.3M | 0.15% | 79 |
|
|
2022
Q4 | $111M | Buy |
2,172,900
+448,500
| +26% | +$21.5M | 0.26% | 51 |
|
|
2022
Q3 | $75.5M | Sell |
1,724,400
-309,600
| -15% | -$15M | 0.15% | 84 |
|
|
2022
Q2 | $107M | Sell |
2,034,000
-1,156,600
| -36% | -$58.9M | 0.17% | 66 |
|
|
2022
Q1 | $165M | Sell |
3,190,600
-331,400
| -9% | -$17.2M | 0.16% | 65 |
|
|
2021
Q4 | $208M | Buy |
3,522,000
+393,400
| +13% | +$19.5M | 0.17% | 58 |
|
|
2021
Q3 | $135M | Buy |
3,128,600
+1,263,400
| +68% | +$56M | 0.15% | 88 |
|
|
2021
Q2 | $73M | Sell |
1,865,200
-214,000
| -10% | -$8.32M | 0.09% | 166 |
|
|
2021
Q1 | $75.3M | Buy |
2,079,200
+238,400
| +13% | +$8.46M | 0.11% | 131 |
|
|
2020
Q4 | $67.8M | Buy |
1,840,800
+991,171
| +117% | +$36.4M | 0.12% | 124 |
|
|
2020
Q3 | $29.6M | Sell |
849,629
-333,908
| -28% | -$11.7M | 0.09% | 168 |
|
|
2020
Q2 | $36.7M | Sell |
1,183,537
-288,796
| -20% | -$9.81M | 0.17% | 95 |
|
|
2020
Q1 | $45.6M | Buy |
1,472,333
+757,616
| +106% | +$25.8M | 0.37% | 36 |
|
|
2019
Q4 | $26.6M | Sell |
714,717
-145,979
| -17% | -$5.2M | 0.18% | 93 |
|
|
2019
Q3 | $29.3M | Buy |
860,696
+362,786
| +73% | +$13.2M | 0.24% | 58 |
|
|
2019
Q2 | $20.5M | Buy |
497,910
+249,904
| +101% | +$9.92M | 0.19% | 87 |
|
|
2019
Q1 | $9.99M | Sell |
248,006
-257,176
| -51% | -$10.3M | 0.11% | 195 |
|
|
2018
Q4 | $20.9M | Buy |
505,182
+326,424
| +183% | +$13.6M | 0.18% | 101 |
|
|
2018
Q3 | $7.47M | Sell |
178,758
-8,432
| -5% | -$325K | 0.06% | 382 |
|
|
2018
Q2 | $6.44M | Sell |
187,190
-132,383
| -41% | -$4.52M | 0.06% | 418 |
|
|
2018
Q1 | $10.8M | Sell |
319,573
-374,908
| -54% | -$12.9M | 0.11% | 202 |
|
|
2017
Q4 | $23.9M | Buy |
694,481
+12,859
| +2% | +$438K | 0.17% | 109 |
|
|
2017
Q3 | $23.1M | Buy |
681,622
+225,240
| +49% | +$7.24M | 0.21% | 87 |
|
|
2017
Q2 | $14.5M | Sell |
456,382
-28,880
| -6% | -$911K | 0.15% | 135 |
|
|
2017
Q1 | $15.8M | Sell |
485,262
-885,149
| -65% | -$27.9M | 0.18% | 102 |
|
|
2016
Q4 | $42.2M | Buy |
1,370,411
+255,911
| +23% | +$7.81M | 0.41% | 33 |
|
|
2016
Q3 | $35.8M | Buy |
1,114,500
+110,354
| +11% | +$3.69M | 0.39% | 41 |
|
|
2016
Q2 | $33.5M | Buy |
1,004,146
+121,632
| +14% | +$3.88M | 0.4% | 32 |
|
|
2016
Q1 | $24.8M | Buy |
882,514
+327,056
| +59% | +$9.34M | 0.35% | 31 |
|
|
2015
Q4 | $17M | Buy |
555,458
+286,056
| +106% | +$9M | 0.2% | 70 |
|
|
2015
Q3 | $8.03M | Buy |
269,402
+231,880
| +618% | +$7.43M | 0.11% | 197 |
|
|
2015
Q2 | $1.19M | Sell |
37,522
-90,961
| -71% | -$2.96M | 0.02% | 1078 |
|
|
2015
Q1 | $4.24M | Buy |
128,483
+127,429
| +12,090% | +$4.05M | 0.07% | 304 |
|
|
2014
Q4 | $31K | Buy |
+1,054
| New | +$30.2K | ﹤0.01% | 3706 |
|
Other funds holding PFE
VCM
VPM
Group One Trading's PFE Position: Q1 2026 in Review
Group One Trading increased its Pfizer (PFE) stake by 271% in Q1 2026, buying an estimated $11.5M and bringing the position to 592,233 shares worth $16.6M. The position accounts for 0.03% of the portfolio, ranked #579.
Group One Trading first reported a position in PFE in Q4 2014 and has held it in 32 quarters since. The position peaked at $32.9M in Q2 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Group One Trading held 592,233 shares of Pfizer worth $16.6M as of Q1 2026.
- Group One Trading bought 432,806 Pfizer shares in Q1 2026, an estimated $11.5M.
- Pfizer made up 0.03% of Group One Trading's portfolio in Q1 2026, its #579 holding.
- Group One Trading first reported a position in Pfizer in Q4 2014 and has held it in 32 quarters since.
- Group One Trading's Pfizer position peaked at $32.9M in Q2 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.